Medizinische Universität Graz - Research portal
Lileg Brigitte |
** = Publications listed in SCI/SSCI/Pubmed
2024
Full paper/article (Journal)
** Zweiker, D; Bergler-Klein, J; Fiedler, L; Toth, GG; Achleitner, R; Schratter, A; Stix, G; Gabriel, H; Binder, RK; Rammer, M; Pfeffer, M; Vock, P; Lileg, B; Steinwender, C; Sihorsch, K; Hintringer, F; Adukauskaite, A; Martinek, M; Sturmberger, T; Ablasser, K; Zirlik, A; Scherr, D
Left Atrial Appendage Closure in Atrial Fibrillation Patients with Cancer.
J Clin Med. 2024; 13(21):
Doi: 10.3390/jcm13216514
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2022
Full paper/article (Journal)
** Zweiker, D; Fiedler, L; Toth, GG; Strouhal, A; Delle-Karth, G; Stix, G; Gabriel, H; Binder, RK; Rammer, M; Pfeffer, M; Vock, P; Lileg, B; Steinwender, C; Sihorsch, K; Hintringer, F; Mueller, S; Barbieri, F; Martinek, M; Tkalec, W; Verheyen, N; Ablasser, K; Zirlik, A; Scherr, D
Not to Rush-Laboratory Parameters and Procedural Complications in Patients Undergoing Left Atrial Appendage Closure.
J Clin Med. 2022; 11(21):
Doi: 10.3390/jcm11216548
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Full paper/article (Journal)
** Zweiker, D; Sieghartsleitner, R; Fiedler, L; Toth, GG; Luha, O; Stix, G; Gabriel, H; Vock, P; Lileg, B; Strouhal, A; Delle-Karth, G; Pfeffer, M; Aichinger, J; Tkalec, W; Steinwender, C; Sihorsch, K; Binder, RK; Rammer, M; Barbieri, F; Mueller, S; Verheyen, N; Ablasser, K; Zirlik, A; Scherr, D
Indications and Outcome in Patients Undergoing Left Atrial Appendage Closure-The Austrian LAAC Registry.
J Clin Med. 2020; 9(10):
Doi: 10.3390/jcm9103274
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2007
Abstract (Journal)
** Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H
Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166.
[Poster]
Web of Science
2006
Abstract (Journal)
** Bauernhofer, T; Samonigg, H; Regitnik, P; Lileg, B; Weizer, W; Waxenecker, G; Kainer, M; Wiederkum, S; Loibner, H; Kircheis, R
A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion.
J CLIN ONCOL. 24(18):111S-111S.-Asco-Meetung; 2.-6. Juni 2006; Atlanta/ Georgia, USA.
[Poster]
Web of Science
** Loibner, H; Bauernhofer, T; Samonigg, H; Regitnig, P; Weitzer, W; Lileg, B; Waxenecker, G; Kainer, M; Wiederkum, S; Schuster, M; Kircheis, R
A phase I/II, open label trial with the Lewis Y specific humanized monoclonal antibody IGN311 in patients with malignant effusions
J IMMUNOTHER. 29(6):634-634.-Meeting Society of Immunotherapy, 21st annual meeting; 26.-29. Oktober 2006; Los Angeles, USA.
[Poster]
Web of Science
2003
Full paper/article (Journal)
** Pokrajac, B; Wolfram, R; Lileg, B; Minar, E
Endovascular Brachytherapy in Peripheral Arteries: Solution for Restenosis or False Hope?
Curr Treat Options Cardiovasc Med. 2003; 5(2):121-126
Doi: 10.1007/s11936-003-0020-1
PubMed
FullText
FullText_MUG